Myrexis (MYRX)
Myrexis Market Cap: 64.89M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
MYRX Market Cap Rankings
| Overall | 18th percentile | 3803 of 4663 |
| Sector | 23rd percentile | 401 of 525 in Healthcare |
| Industry | 14th percentile | 12 of 14 in Drugs - Generic |
MYRX Market Cap Range, Past 5 Years
| Minimum | 64.89M | May 30 2012 |
| Maximum | 140.93M | Sep 2009 |
| Average | 96.02M |
About Market Capitalization
Market Capitalization (Market Cap) is a measurement of business value based on share price and number of shares outstanding. It generally represents the market's view of a company's stock value and is a determining factor in stock valuation.
For example, if a company has 1.5 million shares outstanding at a share price of $25, its market cap is $37.5 million (1.5 million x $25). Companies can be categorized based upon the size of their market capitalization.
There are five basic groups: mega-cap (market cap over $200B), large-cap ($10B–$200B), mid-cap ($2B–$10B), small-cap ($300M–$2B), and micro-cap ($50M-$300M). Market cap is not always an accurate indication of value because it does not account for debt and other factors.
Learn More
You may also be interested in these MYRX related companies
MYRX News
$MYRX Insider Buy: $100K of stock bought by Belle Gerald P. between May 15, 2012 - May 16, 2012 http://stks.co/3sqN
about 13 days ago by MarketBrief
about 13 days ago by MarketBrief
Myrexis Appoints New Executive Management Team in Alignment With Strategic Initiatives
May 11, 8:00AM Benzinga
May 11, 8:00AM Benzinga
Listen to $MYRX Q2 2012 earnings call - live at 04:30 PM, ondemand after - http://stks.co/2Kri
about 111 days ago by earningscast
about 111 days ago by earningscast
Myrexis to Hold Conference Call to Discuss Second Fiscal Quarter 2012 Financial Results
Feb 03, 8:30AM GlobeNewswire
Feb 03, 8:30AM GlobeNewswire
$MYRX Insider Buy: $262K of stock bought by Jason Aryeh (Director) between November 29, 2011 - November 30, 2011 http://stks.co/1TTC
about 173 days ago by MarketBrief
about 173 days ago by MarketBrief
$MYRX Insider Buy: $262K of stock bought by Jason Aryeh (Director) between November 29, 2011 - November 30, 2011 http://stks.co/1S2Y
about 175 days ago by MarketBrief
about 175 days ago by MarketBrief
$MYRX Insider Buy: $262K of stock bought by Jason Aryeh (Director) between November 29, 2011 - November 30, 2011 http://stks.co/1Q4D
about 176 days ago by MarketBrief
about 176 days ago by MarketBrief
$MYRX Insider Buy: $262K of stock bought by Jason Aryeh (Director) between November 29, 2011 - November 30, 2011 http://stks.co/1Os7
about 177 days ago by MarketBrief
about 177 days ago by MarketBrief
$MYRX Insider Buy: $187K of stock bought by Jason Aryeh (Director) between December 1, 2011 - December 2, 2011 http://stks.co/1OeX
about 177 days ago by MarketBrief
about 177 days ago by MarketBrief
$MYRX Insider Buy: $262K of stock bought by Jason Aryeh (Director) between November 29, 2011 - November 30, 2011 http://stks.co/1Nev
about 178 days ago by MarketBrief
about 178 days ago by MarketBrief
$MYRX Insider Buy: $262K of stock bought by Jason Aryeh (Director) between November 29, 2011 - November 30, 2011 http://stks.co/1MwD
about 180 days ago by MarketBrief
about 180 days ago by MarketBrief
Myrexis Inc. (MYRX) Director Purchases 101,700 Shares Over Last Two Days
Dec 01, 4:56PM Street Insider
Dec 01, 4:56PM Street Insider
$MYRX Insider Buy: $262K of stock bought by Jason Aryeh (Director) between November 29, 2011 - November 30, 2011 http://stks.co/1LiD
about 181 days ago by MarketBrief
about 181 days ago by MarketBrief
$MYRX--Insider purchased 106,791 shares at $2.54. Stock closed at $2.56. Do your own research. Low float, decent volume.
about 183 days ago by MicroInsider
about 183 days ago by MicroInsider
$MYRX Insider Buy: $271K of stock bought by Jason Aryeh (Director) between November 25, 2011 - November 28, 2011 http://stks.co/1JNm
about 183 days ago by MarketBrief
about 183 days ago by MarketBrief
$MYRX Insider Buy: $196K of stock bought by Jason Aryeh (Director) between November 22, 2011 - November 23, 2011 http://stks.co/1Gq0
about 187 days ago by MarketBrief
about 187 days ago by MarketBrief
Myrexis (NYRX) to Cut Headcount By an Additional 20%; Total Now at 55% for Year
Nov 18, 11:47AM Street Insider
Nov 18, 11:47AM Street Insider
Myrexis announces corporate reorganization to focus on development initiatives
Nov 18, 11:46AM FlyOnTheWall
Nov 18, 11:46AM FlyOnTheWall
Myrexis Announces Corporate Reorganization to Focus on Development Objectives
Nov 18, 11:46AM Benzinga
Nov 18, 11:46AM Benzinga
Myrexis Presents at 2011 EORTC/NCI/AACR Molecular Targets and Cancer Therapeutics Symposium
Nov 14, 9:05AM GlobeNewswire
Nov 14, 9:05AM GlobeNewswire
CORRECTION -- Myrexis to Hold Conference Call to Discuss First Quarter 2012 Financial Results
Nov 03, 6:03PM GlobeNewswire
Nov 03, 6:03PM GlobeNewswire
Myrexis to Hold Conference Call to Discuss First Quarter 2012 Financial Results
Nov 03, 4:02PM GlobeNewswire
Nov 03, 4:02PM GlobeNewswire
Myrexis to Present at 2011 EORTC/NCI/AACR Molecular Targets and Cancer Therapeutics Symposium
Nov 03, 4:02PM GlobeNewswire
Nov 03, 4:02PM GlobeNewswire
$MYRX filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/k2T
about 222 days ago by MarketBrief
about 222 days ago by MarketBrief
$MYRX shares halted: Q4 loss of 31c, vs. cons. 35c loss, sales $185K; names new CEO, CFO; to resume at 4:30pm ET
about 265 days ago by Street_Insider
about 265 days ago by Street_Insider
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| MYRX | 2.45 | -0.07 | -2.78% | 66.48M |
| MYN | 14.42 | +0.01 | +0.07% | |
| MYM | 14.28 | +0.02 | +0.14% | |
| MYL | 21.53 | -0.36 | -1.64% | 9.345B |
| MYJ | 16.13 | -0.14 | -0.86% | |
| MYGN | 24.98 | -0.22 | -0.87% | 2.124B |
| MYF | 15.96 | -0.14 | -0.87% | |
| MYC | 16.30 | +0.01 | +0.06% | |
| MY | 1.38 | -0.14 | -9.21% | 190.00M |
| MXWL | 6.46 | -0.60 | -8.50% | 199.16M |